Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination

Melanoma patients with regional metastatic disease are at high risk for recurrence and metastatic disease, despite radical lymph node dissection (RLND). We investigated the immunologic response and clinical outcome to adjuvant dendritic cell (DC) vaccination in melanoma patients with regional metast...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Bol, Kalijn F, Aarntzen, Erik H J G, Hout, Florentien E M in 't, Schreibelt, Gerty, Creemers, Jeroen H A, Lesterhuis, W Joost, Gerritsen, Winald R, Grunhagen, Dirk J, Verhoef, Cornelis, Punt, Cornelis J A, Bonenkamp, Johannes J, de Wilt, Johannes H W, Figdor, Carl G, de Vries, I Jolanda M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760342/
https://ncbi.nlm.nih.gov/pubmed/26942068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1057673
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak